Author: Tanjid Osman
Tanjid Osman is a dedicated news journalist at Daljoog News, covering a wide range of topics, including General News, World Affairs, Business, Technology, Politics, Finance, Health, Lifestyle, Sports, and Travel. With a keen eye for detail and a passion for delivering accurate and insightful stories, he keeps readers informed on the latest developments from around the globe.
As global demand grows for green shipping solutions, ammonia is emerging as a key carbon-neutral fuel for the future. Countries in Asia, especially Japan, China, and South Korea, are now competing for leadership in the new ammonia-powered ships market. Japan has made a notable breakthrough with Sasaki Shipbuilding securing the world’s first order for an ammonia bunkering vessel. These ships are designed to carry and supply ammonia fuel to other vessels. Ammonia is seen as a promising alternative to traditional fuels because it emits no carbon when burned and has 1.5 times more energy density than liquefied hydrogen. It is…
A new direct flight from Montreal to Belize is set to change how European travelers reach the Central American destination. Starting December 8, 2025, Air Canada will operate a nonstop service between Montreal-Trudeau International Airport and Philip Goldson International Airport in Belize City. This marks the first direct link between Montreal and Belize, offering same-day travel from Europe through a single connection. The move is expected to boost Belize’s growing appeal among European visitors, making the journey shorter, easier, and more affordable. The new route will run once a week. Flights will leave Montreal each Monday in the late afternoon…
New research shows that Ozempic and similar medications could help men with obesity or Type 2 diabetes boost their testosterone levels. The findings come from SSM Health St. Louis University Hospital, where a team studied 110 men who were using GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), or tirzepatide (Zepbound). These men were around 54 years old and were not using testosterone replacement or other hormone therapy. Over an 18-month period, they lost about 10% of their body weight on average. During that time, the number of men with normal testosterone levels rose from 53% to 77%.…
Amanda Shires is returning with powerful new music after a quiet period following her public split from fellow musician Jason Isbell. Her upcoming album, Nobody’s Girl, scheduled for release on September 26, is a deeply personal project that shines a light on resilience, recovery, and the strength found in vulnerability. The first single from the album, A Way It Goes, is now available alongside a music video. The song gives listeners a raw but hopeful glimpse into Shires’ emotional journey after her divorce, capturing both pain and strength in a way only she can. Shires recently shared that she was…
The Sparks kept their energy high and never slowed down in a strong 99-80 victory against the Washington Mystics. The game was filled with fast plays, tough defense, and teamwork that showed the Sparks’ best basketball this season. As the first half neared its end, Dearica Hamby made a dramatic shot. The ball hit the front rim and looked like it would bounce out. But the spin on the ball carried it back to the rim. After bouncing twice more, it finally fell in. Hamby fell with the ball, and her teammates rushed to celebrate. The crowd at Crypto.com Arena…
Kyle Schwarber stole the show in the All-Star Game with a stunning performance in the swing-off, earning the Ted Williams All-Star Game Most Valuable Player Award. The National League won the game 7-6 after out-homering the American League 4-3. The AL had tied the score in the ninth inning, but Schwarber’s three home runs in the swing-off sealed the victory for the NL. Schwarber hit all three of his swings for home runs. They flew 428 feet, 461 feet, and 382 feet. His powerful hits gave the National League a one-homer lead going into the final round. The AL’s Jonathan…
Mira Murati, the former chief technology officer of OpenAI, has announced a major milestone for her new venture. Her artificial intelligence startup, Thinking Machines Lab, has secured $2 billion in funding. The company plans to introduce its first product within the next few months. Murati became a well-known name in the tech world in 2023 when she briefly led OpenAI as interim CEO. She took on that role after Sam Altman was temporarily removed by the board. After leaving OpenAI in September 2024, she launched Thinking Machines Lab in February 2025. This week, Murati posted on social media platform X…
Advanced Micro Devices (AMD) is preparing to resume exports of its MI308 artificial intelligence chips to China. This move follows the U.S. Commerce Department’s decision to restart the review of license applications needed for such exports. After receiving approval, AMD plans to begin shipments immediately. The company’s stock rose more than 6% following the announcement. An AMD spokesperson said the company welcomed the efforts by the Trump administration to improve trade ties and support U.S. leadership in artificial intelligence. This progress comes after months of tension between the U.S. and China, fueled by trade restrictions and tariffs. Earlier this year,…
Parents and guardians in the South East are calling for a major overhaul of the Special Educational Needs and Disabilities (SEND) system. They say the current setup is harming their children’s mental health. Tora, a mother from East Sussex, said the lack of SEND support has hurt her 16-year-old son Mason’s wellbeing. Mason has autism, type 1 diabetes, and a severe learning disability. He was asked to leave his special needs school last October because the school could no longer meet his needs. Since then, Tora has applied to 20 different schools for her son. Each one rejected him, saying…
A recent study shows that popular GLP-1 medications help patients lose weight even when their access is inconsistent. This research was shared at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco. GLP-1 drugs like semaglutide and tirzepatide are widely used to fight obesity. But many patients face problems getting their medication regularly. Supply shortages and insurance issues often cause these interruptions. Kaelen L. Medeiros, M.S., director of data and research at a private weight-loss company in New York, explained, “Patients taking GLP-1 treatments often face challenges consistently accessing their medications due to supply shortages or insurance coverage obstacles.”…












